Dr. Aditi Aggarwal

Dr. Aditi Aggarwal

Dr. Aditi Aggarwal is an expert Radiation Oncologist trained from the prestigious Tata Memorial Hospital, Mumbai. She has extensive training in all modern and precise techniques of radiation including IMRT, IGRT, SRS, SBRT, and SRT, and has more than 10 Years of experience in the field of Radiation Oncology. She has worked as Founder Faculty at the National Cancer Institute, All India Institute of Medical Sciences (AIIMS), Jhajjar where she started Radiation services including Brachytherapy.

After doing her MBBS from Lady Hardinge Medical College, Delhi, where she won several Gold Medals and Awards of Academic Excellence, she chose Radiation Oncology as her Career. She has several publications in various National as well as International Journals. She has presented her research work at various national and international conferences and has been involved in the teaching and training of young doctors.

She has been involved in various research projects at Tata Memorial Hospital and has a special interest in Gynecological, Brain and Head Neck and Gastrointestinal Tumors and Sarcomas.

She has been trained and has worked at the best Institutes in the country in Oncology including Tata Memorial Hospital, Mumbai, and All India Institute of Medical Sciences (AIIMS), Jhajjar.

 

Professional Memberships

  • Indian Medical Association (IMA)
  • Life Member Oncology Forum Delhi NCR
  • Indian Brachytherapy Society (IBS)
  • Association of Radiation Oncologists of India (AROI)
  • Association of Radiation Oncologists of India (AROI) Maharashtra chapter

 

Specialty Interests

  • Stereotactic Radiosurgery (SRS) and Stereotactic Radiotherapy (SRT) for Brain tumors
  • Intensity Modulated Radiotherapy for Head & Neck, Breast, Gastrointestinal and Gynecological cancers, and Sarcomas.
  • Cancer Prevention especially for Breast and cervical cancers
  • Stereotactic Body Radiotherapy(SBRT) for Lung, Liver cancers, for Bone metastasis.
  • Interstitial Brachytherapy for head neck, breast, Gynecological cancers, and Sarcomas.

 

Previous Experience

  • Faculty National Cancer Institute, AIIMS
  • Senior Research Associate at MAMC and LNJP Hospital, Delhi
  • Associate Consultant at IOSPL, Fortis Noida
  • Senior Resident at Tata Memorial Hospital

 

Education and Fellowships

  • MBBS FROM Lady Hardinge Medical College, Delhi
  • MD Radiation Oncology from VMMC and Safdarjang Hospital, Delhi (Delhi University)
  • PDCR from Catalyst Clinical Sciences, Pune

 

Awards and Honors

  • Young Investigator award by British Journal of Radiology (2014) Presentation at ASTRO 2012 at Boston, USA
     

 

Research and Publications

  • >Deepak Gupta, Pragya Shukla, Shyam Singh Bisht, Aditi Aggarwal, Ankur Dhawan, Mohan Chand Pant, Madan Lal Bhatt, Rajeev Gupta, Kirti Srivastava, Seema Gupta & Madhu Srivastava. Comparative study of efficacy, tolerability of four-field box technique vs. two fields anterior-posterior technique in locally advanced carcinoma cervix: A prospective analysis. Cancer Biology and Therapy. 05/2009; 8:9, 759-764.

 

  • Aditi Aggarwal, Supriya Chopra, Siji N Paul, Reena Engineer, Shyam K Shrivastava. Evaluation of Internal Target Volume in patients undergoing Image Guided Intensity Modulated adjuvant radiation for Gastric Cancer. British Journal of Radiology. 11/2013; 10/1259.

 

  • Supriya Chopra, Aditi Aggarwal, Reena Engineer, Tapas Dora, Biji Thomas, SupriyaSonawone, Siji N Paul, Sadhna Kannan, Prachi Patil, Shaesta Mehta, Shyam Kishore Shrivastava. IMRT is not superior to 3DCRT for adjuvant gastric cancer radiation: A matched pair analysis. JCRT.10/2015;11(3): 623-629.

 

  • Sameer Rastogi, Sameer Bakshi, Aditi Aggarwal. Antiemetic Trials in Oncology: What should be done next? Natl Med J India. 29(2).Mar-Apr 2016. 8. Sameer Rastogi, S V Mishra, and Aditi Aggarwal. Overall Survival as Primary End Point in Advanced Soft Tissue Sarcoma and its Surrogates: A Bemusing Mirage. Sarcoma Res Int. 7/2016; 3(2): 1031.

 

  • Sameer Rastogi., Aditi Aggarwal.,. Organization of Chemotherapy and Systemic Therapy Services in India: Devil lies in details. Journal of Global Oncology. 2017 ;3(2): 182-183.

 

  • Atul Sharma, Aditi Aggarwal, IlavarasiVanidassane et al Pazopanib toxicity in a metastatic sarcoma cohort: Are Indian patients different?. Annals of Oncology (2017) 28 (suppl_10): x149-x152. 10.1093/annonc/mdx675.

 

  • Aditi Aggarwal Anurita Srivastava, Saluja S, Kishore Singh, Arun Kumar Rathi, Savita Arora. The fate of incidental gall bladder cancers: A single-center experience.,. E-poster presented at ICC 2017.

 

  • Aditi Aggarwal, Vinod Sharma, Sameer Rastogi. Adding olanzapine to three drugs antiemetic regimen: Is it time to jump the gun? IJMPO 3/2018; 39 (2):125.

 

  • Atul Sharma, Naresh G, Aditi Aggarwal, Adarsh Barwad, Ekta Dhamija, Rambha Panday, Venkat Sampatkumar, Anjali v Ramdulari, Sameer Rastogi . Retrospective analysis of management and outcome of advanced soft tissue sarcomas (STS) with rare histology. J Clin Oncol 36, 2018 (suppl; Abstr e23564)

 

  • Aditi Aggarwal, Atul Sharma, Sameer Rastogi. The quest for histology-driven neoadjuvant chemotherapy in soft tissue sarcoma: end of the road or just the beginning? Epub ahead of Print.2018

 

  • Aparna Sharma, Ilavarasi, Adarsh Barwad, Ekta Dhamija, Aditi Aggarwal. Pazopanib toxicity in metastatic sarcoma cohort. Accepted in Indian Journal of Cancer

 

  • Management of Gynaecological malignancies- A case-based approach. Chapter in Textbook of Obstetrics and Gynaecology. A K Rathi, Aditi Aggarwal. 2018

 

  • Umesh Mahantshetty, Aditi Aggarwal, Balasubramanium Ganesh, SushamaSaoba, Safoora Mulla, Reena Engineer, Supriya Chopra, Amita Maheshwari, Rajendra Kerkar, Shylasree T S, Jaya Ghosh, Sudeep Gupta, ShyamkishoreShrivasatava. Clinical Outcome of Early-Stage Endometrioid Adenocarcinoma: A Tertiary Cancer Center Experience. International Journal of Gynecological Cancer .10/2013; 23(8):1446-1452.

 

  • Supriya Chopra, Aditi Aggarwal, Reena Engineer, Siji Paul, Biji Thomas, Shaesta Mehta, Prachi Patil, Shailesh Shrikhande, Mahesh Goel, and Shyam Shrivastava. Acute Toxicity And Compliance With Tomotherapy Based Adjuvant Intensity Modulated Radiotherapy In Patients With Gastric Cancer: Results From Prospective Study. Annals of Oncology. 2013; 24(4):iv63.

 

  • Rakesh Jalali, Jayant S GODA, Shirley Lewis, Aditi Aggarwal, Sridhar Epari, Shradha Churi, Padmavati A, Tejpal Gupta, AliasgarMoiyadi. Impact of Oligodendroglial component in Glioblastoma (GBM-O): Is the outcome more favorable than Glioblastoma?. Clinical Neurology and Neusosurgery. 8/2015; 135: 46-53.

 

  • Roopam Srivastava, P.K. Sharma, Aditi Aggarwal, Gagan Saini. Adaptive Radiotherapy: A hybrid (on-line image guidance + off-line adaptive) approach for head and neck cancer. Poster in ESTRO 2016

 

  • Sameer Rastogi, Aditi Aggarwal. Discordance of histopathological diagnosis of patients with soft tissue sarcoma referred to the tertiary care center. Journal of Clinical Oncology. 2017 35:15_suppl, 11064-11064.

 

  • Manyoo A Agarwal, Aditi Aggarwal, Sameer Rastogi, Hector O Ventura, Carl J Lavie.Cardiovascular Disease Burden in Cancer Patients from 2003 to 2014. European Heart Journal Quality of Care and Clinical Outcomes, 2017;4(1): 6970.

 

  • Sameer Rastogi, Aditi Aggarwal, Akash Tiwari, Vinod Sharma. Chemotherapy in nonmetastatic osteosarcoma: Recent advances and implication for developing countries. Journal of Global Oncology. 2018; 4: 1-5.

 

  • Sameer Rastogi, Aditi, Aggarwal, IlavarasiVanidassaneGeddis Trial, and Its Primary End PointThere is An Elephant in the Room! Clin Oncol. 2018; 3: 1414.

 

  • Sameer Rastogi, Atul Sharma, Aditi Aggarwal Naresh G, Adarsh Barwad, Ekta Dhamija, Rambha Panday. Outcomes of advanced soft tissue sarcoma from dedicated medical oncology sarcoma clinic in North India and evaluation of the respective model. J Clin Oncol 36, 2018 (suppl; abstr e23561)

 

  • Sameer Rastogi, Ekta Dhamija, Adarsh Barwad, Aditi Aggarwal, Atul Sharma, Rambha Panday. Advanced dermatofibrosarcoma protuberans treatment with imatinib Experience from dedicated sarcoma medical oncology clinic in India. Accepted for publication in JGO June 2018

 

  • Saurabh Roy, V.Subramani, Kishore Singh, Arun Kumar Rathi, Savita Arora, Aditi Aggarwal. Study of effects of Dwell Time Deviation Constraints on Inverse planning simulated annealing optimized plans of intracavitary brachytherapy of carcinoma cervix. JCRT. Epub ahead of print 2018